Has Steven Edmundowicz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $189,967 in general payments to Steven Edmundowicz, MD across 125 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Edmundowicz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Edmundowicz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Edmundowicz, MD

Gastroenterology · Aurora, CONPI 1780601229

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.4%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Olympus Corporation accounts for 72.8% of it on its own, with 11 other manufacturers making up the rest. Among gastroenterology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$189,967in general payments, 2019–2025

Across 125 payments — averaging $1519.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Olympus Corporation$138K
Boston Scientific$19K
Olympus America Inc.$13K
Olympus Corporation Of The Americas$10K
Ambu A/s$7K
Olympus Medical Systems Corporation$1K
plus $848 from 6 others

$458,041in research payments, 2019–2025

Across 8 payments — averaging $57,255 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Olympus Corporation$207K
Olympus Corporation Of The Americas$206K
Chirhoclin, Inc.$45K

What the payments were for

Consulting fees$112,92559%
Speaking & faculty fees$19,76810%
Travel & lodging$53,84628%
Food & beverage$3,1512%
Gifts$2770%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Olympus Corporation	83	$138,369
Boston Scientific	14	$19,211
Olympus America Inc.	10	$13,480
Olympus Corporation Of The Americas	3	$9,783
Ambu A/s	1	$7,159
Olympus Medical Systems Corporation	7	$1,116
Ambu Inc.	2	$234
Fujifilm Healthcare Americas Corporation	1	$194
Aries Pharmaceuticals, Inc.	1	$174
Braintree Laboratories, Inc.	1	$129
Conmed Corporation	1	$66
Medtronic	1	$50

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GENERAL - THERAPIES$17,818
EVIS EXERA III DUODENOVIDEOSCOPE$11,110
EVIS EXERA III COLONOVIDEOSCOPE$9,921
Olympus Biliary Devices$2,768
GASTROINTESTINAL VIDEOSCOPE$1,399
EVIS EUS ENDOSCOPIC ULTRASOUND CENTER$1,399
EVIS EXERA II ULTRASOUND GASTROVIDEOSCOPE$1,399
GENERAL - BILIARY DEVICES$236
FUJIFILM$194
REMIMAZOLAM$174
Endocuff Vision$149
DISPOSABLE TRIPLE LUMEN SPHINCTEROTOME$149
Single Use Electrosurgical Knife KD-655$149
Single Use Electrosurgical Hemostatic Forceps$149
SUFLAVE$129

How this compares

$189,967 in reported general payments places this provider in the 95th percentile of 304 gastroenterology providers in Colorado.

See all gastroenterology providers in Colorado →

Medicare billing

Part B allowed, 2024

$93,356

Medicare patients

224

Services billed

561

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OxycontinOxycodone Hcl	21	$12,547
Dexlansoprazole DrDexlansoprazole	14	$3,440
Sucralfate	29	$2,729
Ursodiol	13	$2,107
Omeprazole	65	$1,126
Vancomycin Hcl	15	$1,096
Pantoprazole Sodium	32	$816
Famotidine	33	$608
Ondansetron OdtOndansetron	14	$447
Oxycodone Hcl	20	$420
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg	12	$295
Hydromorphone Hcl	11	$245
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl	15	$224
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	15	$117
Diazepam	11	$17

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Aurora

Mihir WaghAurora$217K
Raj ShahAurora$98K
Hazem HammadAurora$57K
Jennifer ChristieAurora$45K
Mohammad BilalAurora$36K
Benjamin ClickAurora$35K
Sachin WaniAurora$31K
Frank ScottAurora$12K
Mark GerichAurora$9K
Ariana GreenwoodAurora$8K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →